Tirzepatide Pharma DBA "MayMay Biologics" A 506e Pharma
Partner with us
Effective Q1 2027, our company, formerly known as Zeptide Pharma (and operating under the name Tirzepatide Pharma) will officially rebrand as MayMag Biologics. This strategic transition establishes a distinct corporate identity and eliminates market confusion between our company and the active pharmaceutical ingredient (API) generically known as Tirzepatide.
Large Scale 506e Biologics Manufacturer
Generic Manufacturer of Sterile Injectable Biologics, WFI, Epinephrine Pens, and Rheumatoid Auto Injectors
We're not a retail 503b compounding pharma for hospitals and clinics. We are 506e specializing in large-scale manufacturing of generics and biosimilar biologics under FDA-shortlisted drugs
Industrial Scale Manufacturer of FDA Short Listed Drugs
Bac-Water Manufacturer
The Science of Safety
Bacteriostatic Water for Injection (BWFI) is a crucial component in modern medicine, used to dilute or dissolve medications for injection. Unlike regular sterile water, bacteriostatic water contains exactly 0.9% benzyl alcohol, which acts as a preservative to halt the growth of most potentially contaminating bacteria. This allows vials to be safely re-entered multiple times for multi-dose applications.
Quality Control Assurance Framework at MayMag Biologics
The Science of Reliability. Our Dual-Layered Quality Framework In the specialized field of peptide therapy, clinical outcomes are directly tied to the scientific rigor behind the manufacturing process. For medical institutions and providers utilizing private label peptide services, understanding the testing protocols behind the products is paramount.
MayMag Biologics (formerly Zeptide Pharma) is a 506e USA-based large-scale industrial manufacturer of insulin pens, anti-inflammatory auto pens, insulin nasal sprays, weight loss, and ophthalmology products
An IND outsourcing Facility for the development of once-a-week oral GLP1, generic diabetic biosimilars, Bacteriostatic Water, lyophilized peptides, and generic drug manufacturer.
We manufacture 506e Products Only
Industrial Contract Manufacturing Services
Our Core Specialties
Our expertise spans a diversified portfolio of injectable and solid dose medications, supported by dependable international distribution
- Biologics and Insulin: Comprehensive manufacturing of insulin analogs (including aspart premix, aspart vials, glargine, and 70/30 pens), repurposed insulin, and advanced biosimilars.
- Targeted Therapeutics and GLP-1s: Cutting-edge development and production of oral GLP-1 therapeutics, advanced weight-loss treatments, and specialized peptides (Sterile and RUOs).
- Advanced Delivery Systems: Large-scale production of auto-pen medications, epinephrine auto-injectors (EpiPens), nasal sprays, transdermal drug delivery systems, and ophthalmology products.
- Custom Synthesis and API Manufacturing: Expert in-house HPLC drug purification and custom synthesis of DNA, RNA, oligonucleotides, wellness peptides, and human APIs.
- Pharmaceutical Manufacturing: Reliable production of Generic Medicines (OSDs), specialized Derma-Products, and bacteriostatic waters.
Our Biologics Portfolio
Sterile Peptide Vials
Our vial products undergo a meticulous sterilization and filtration process, using a 0.22-micron PES-layered vacuum filter and a 2000ml Foxx Life Sciences Autofil assembly. Each batch ensures your buffer water is filtered into sterile containers, adhering to the highest laboratory standards. Choose products where every detail counts and your peace of mind is guaranteed—start now with our uncompromising filtration solutions.
We Drive Confidence in Every Vial
MayMag Biologics (Formerly Zeptide Pharma)-Be assured, the name change is strictly a rebranding effort. Our customers and industry partners can expect a seamless transition with uninterrupted supply chains, consistent manufacturing processes, and the exact same rigorous quality control standards.
Clinical Purity Backed By Proof
Global Reach & Regulatory Excellence
We facilitate the cGMP manufacture and global supply of finished drug products to premier markets, including North America, Europe, Asia, and the Middle East. Our commitment to compliance is validated by a flawless track record of inspections from the world’s most stringent global regulatory authorities, including:
- USFDA, MHRA (UK), & Health Canada
- ANVISA (Brazil) & PMDA (Japan)
- PIC/S, GMP, TFDA, and the Gulf Cooperation Council (GCC)
